cas 162882-77-1|| where to buy 1-((3R,5R,8R,9R,10S,13S,14S,17S)-3-hydroxy-3,13-diMethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)ethanone

Nom du produit:1-((3R,5R,8R,9R,10S,13S,14S,17S)-3-hydroxy-3,13-diMethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)ethanone

IUPAC Name:1-[(1S,3aS,3bR,5aR,7R,9aS,9bR,11aS)-7-hydroxy-7,11a-dimethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-1-yl]ethan-1-one

Unité d'emballage	Stock disponible	Prix($)	Quantité
CM761423-100mg	in stock	ƏƅƅǺ

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 162882-77-1 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:162882-77-1; Formule moléculaire:C21H34O2; Point de fusion:-; Code SMILES:CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@](C)(O)CC[C@@H]4[C@H]3CC[C@]12C; Densité:

: Numéro de catalogue:CM761423; Poids moléculaire:318.5; Point d'ébullition:; N° Mdl:MFCD30179528; Stockage:

: Steroids; Naturally occurring steroids are estrogen, cortisol, progesterone, and testosterone. Pharmacologically, they are used in several ways: alter steroid metabolism via statins to help lower cholesterol; as corticosteroids to help control inflammation, asthma, and lupus; and other forms to help hormone deficiency, such as delayed puberty, as well as diseases that result in loss of lean muscle mass, such as cancer and AIDS.; Steroids Wholesale,Steroid Compounds Supplier - Chemenu; Steroids Wholesale,Steroid Compounds Supplier,Wholesale Steroids,Steriods Supplier; Chemenu is your trusted wholesale supplier of steroid compounds. Explore our wide range of wholesale steroids and choose from high-quality products for your specific needs.Experience the convenience of purchasing wholesale steroids from Chemenu and elevate your performance goals.

: Zuranolone; ZURZUVAE was approved by the FDA in August 2023 as the first-and-only oral treatment specifically indicated for adults with postpartum depression (PPD). Zuranolone is a next-generation positive allosteric modulator (PAM) of GABAA receptors being evaluated as a treatment for various affective disorders.